Clinical Trial Update: Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemotherapy with radiotherapy with or without amifostine for xerostomia, mucositis, and dysphagia in head and neck cancer; the study w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Dysphagia, Head and Neck Cancer | Phase 2 | Status: TERMINATED | Results posted: 2011-12-08